Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Reprogramming 3D environments can create hair follicles in the lab.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

PRP treatment improves chronic tendinopathy, and imaging biomarkers can track tendon changes.

Par3–mInsc and Gαi3 work together to ensure proper cell division orientation in skin development.

A traditional herbal mix from East Nusa Tenggara may help hair regrowth after chemotherapy.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Minoxidil levels measured in human blood.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

A stable, active version of a growth factor was made in bacteria, showing promise for medical use.

A protein called FERONIA helps control root hair growth in response to cold and low nitrogen by activating nutrient-sensing pathways in a plant called Arabidopsis.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.